Antenatal steroid exposure and outcomes of very premature infants: A regional cohort study

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 1, 2014, Pages

  Wong, D ^a   Abdel Latif, M E ^a,b   Kent, Alison L ^a,b  

^a The Australian National University   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; SURFACTANT;

ABORIGINE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHORIOAMNIONITIS; COHORT ANALYSIS; FEMALE; FETUS OUTCOME; FOLLOW UP; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MATERNAL HYPERTENSION; MORTALITY; MULTICENTER STUDY; MULTIPLE PREGNANCY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN MORBIDITY; PATENT DUCTUS ARTERIOSUS; PERINATAL MORBIDITY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; SURVIVAL;

ANTENATAL STEROIDS; NEURODEVELOPMENT; PRETERM NEONATE; SURVIVAL;

ADULT; AUSTRALIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; DEXAMETHASONE; ENTEROCOLITIS, NECROTIZING; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84890426376     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304705     Document Type: Article

References (25)

1. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
2. Mwansa-Kambafwile J, Cousens S, Hansen T, et al. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol 2010;39:i122-33.
3. Roberts D, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006(3):CD004454.
4. Chiswick M. Infants of borderline viability: Ethical and clinical considerations. Semin Fetal Neonatal Med 2008;13:8-15.
5. Doyle LW, Roberts G, Anderson PJ, et al. Outcomes at age 2 years of Infants <28 weeks' gestational age born in Victoria in 2005. J Pediatr 2010;156:49-53.
6. Itabashi K, Horiuchi T, Kusuda S, et al. Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics 2009;123:445-50.
7. Manktelow BN, Lal MK, Field DJ, et al. Antenatal corticosteroids and neonatal outcomes according to gestational age: a cohort study. Arch Dis Child Fetal Neonatal Ed 2010;95:F95-8.
8. Mori R, Kusuda S, Fujimura M. Antenatal corticosteroids promote surival of extremely preterm infants born at 22-23 weeks of gestation. J Pediatr 2011;159:110-14.
9. MacArthur B, Howie RN, Dezoete J, et al. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982;70:99-105.
10. Doyle LW, Kitchen WH, Ford GW, et al. Antenatal steroid therapy and 5-year outcome of extremely low birth weight infants. Obstet Gynecol 1989;73:743-6.
11. Smolders-de Haas H, Neuvel J, Schmand B, et al. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10- to 12-year follow-up. Pediatrics 1990;86:65-70.
12. Doyle LW, Ford GW, Rickards AL, et al. Antenatal corticosteroids and outcome at 14 years of age in chidlren with birthweight less than 1501 grams. Pediatrics 2000;106:E2.
13. Bajuk B. Validation of the neonatal intensive care units' data collection. Proceedings of the 5th Annual Congress of Perinatal Society of Australia and New Zealand, 2001;55.
14. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
15. Luig M, Lui K, Group NaAN. Epidemiology of necrotizing entercolitis - Part I: changing regional trends in extremely preterm infants over 14 years. J Paediatr Child Health 2005;41:169-73.
16. Papile L, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529-34.
17. An International classifi cation of retinopathy of prematurity. Paediatrics 1984;74:127-33.
18. Kent AL, Wright IMR, Abdel-Latif ME, for New South Wales and Australian Capital Territory Neonatal Intensive Care Units Audit Group. Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 2012;129:124-31.
19. Perneger T. What's wrong with Bonferroni adjustments. BMJ 1998;316:1236-8.
20. Chawla S, Natarajan G, Rane S, et al. Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure. J Perinat Med 2010;38:419-23.
21. Kiechl-Kohlendorfer U, Ralser E, Peglow UP, et al. Adverse neurological outcomes in preterm infants: risk factor profiles for different gestational ages. Acta Paediatr 2009;98:792-6.
22. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999;180:1283-8.
23. Romero R, Espinoza J, Goncalves L, et al. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007;25:21-39.
24. Kent AL, Lomas F, Hurrion E, et al. Antenatal steroids may reduce adverse neurological outcome following chorioamnionitis: neurodevelopmental outcome and chorioamnionitis in premature infants. J Paaediatr Child Health 2005;41:186-90.
25. Schenone MH, Aguin E, Li Y, et al. Prenatal prediction of neonatal survival at the borderline viability. J Matern Fetal Neonatal Med 2010;23:1413-8.